Mechanistically, VB directly binds and downregulates CCN1, an oncogenic factor highly expressed in OC, inhibiting the AKT/NF-κB pathway, which plays a central role in regulating tumor progression and macrophage polarization. The gene discussed is AKT1; the disease is neoplasm.